An educational model for understanding contemporary oncology management through advances in clinical trials
“The Preceptorship” is an interactive learning model developed by Professor Eva Segelov covering landmark clinical trials in specific cancers, with mentorship from experts in the field. It has been applied in the areas of lung, colorectal, upper gastro-intestinal and prostate cancers to aid trainees and junior consultants in understanding of the evolution of management and evidence behind contemporary clinical practice. The AGITG will hold a Preceptorship in Rectal Cancer on 4-5 May. Analysis of feedback for the Colorectal Preceptorships won the “Best of the Best Oral Presentations” for Educational Papers at the Clinical Oncological Society of Australia Annual Scientific Meeting 2014.
Applications are now open for the Australasian Gastro-Intestinal Trials Group Rectal Cancer Seminal Advances Preceptorship. Places are limited and expected to fill quickly. The 1 ½ day workshop will cover landmark clinical trials in rectal cancer. Our target participants are trainees and junior specialists (first 5 years of practice) in radiation oncology, medical oncology, surgery and imaging. Successful applicants will be supported (fully paid accommodation and flights) to attend this exciting new initiative.
Areas to be covered include screening, multimodality management of early, locally advanced and metastatic disease and supportive care.
Preceptors include medical oncologists Prof Eva Segelov (Convenor) and A/Prof Niall Tebbutt; radiologist Dr Kirsten Gormly; surgeons A/Prof Andrew Stevenson and Prof Alexander Engel and radiation oncologist A/Prof George Hruby.
With many thanks to Monash University for supporting this preceptorship. Click here for the Monash website.
Professor Eva Segelov, Professor of Medicine
Professor Segelov is Director of Oncology at Monash Health and Monash University, she comes from the University of New South Wales where she was a clinical academic and a senior staff specialist in medical oncology. She previously worked at the Southwest Sydney Clinical School at Liverpool Hospital and St Vincent’s Clinical School at St Vincent’s Hospital, Sydney.
While her clinical focus has been in the management of patients with breast, upper and lower gastrointestinal cancer and neuroendocrine tumours, Professor Segelov’s research interests are in clinical trials and associated translational research. She has led multiple national and international trials.
As well as serving as a Board member of the Australasian Gastrointestinal Trials Group (AGITG) and Convenor of the AGITG Annual Scientific Meeting, Professor Segelov is the Gastrointestinal Chair for the Clinical Oncology Society of Australia (COSA). She is also the co-Track Chair for GI Cancer at the ESMO Asia annual conference and the Co-Founder of The Commonwealth Neuroendocrine Tumour Collaboration (CommNETS), an international research organisation between Australia, Canada and New Zealand.